Literature DB >> 3059929

Neuropeptides, dopamine, and schizophrenia.

C B Nemeroff1, G Bissette.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3059929     DOI： 10.1111/j.1749-6632.1988.tb42113.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  Dopamine induces Ca2+ signaling in astrocytes through reactive oxygen species generated by monoamine oxidase.

Authors:  Annika Vaarmann; Sonia Gandhi; Andrey Y Abramov
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

2.  Presynaptic dopamine D2-like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones.

Authors:  E Koga; T Momiyama
Journal:  J Physiol       Date:  2000-02-15       Impact factor: 5.182

Review 3.  Cannabis-associated psychosis: current status of research.

Authors:  F Markus Leweke; Christoph W Gerth; Joachim Klosterkötter
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

4.  Presence of somatostatin or neurotensin in lateral septal dopaminergic axon terminals of distinct hypothalamic and midbrain origins: convergence on the somatospiny neurons.

Authors:  R L Jakab; C Leranth
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

5.  Coordinated expression of dopamine receptors in neostriatal medium spiny neurons.

Authors:  D J Surmeier; W J Song; Z Yan
Journal:  J Neurosci       Date:  1996-10-15       Impact factor: 6.167

6.  Two types of neurone in the rat ventral tegmental area and their synaptic inputs.

Authors:  S W Johnson; R A North
Journal:  J Physiol       Date:  1992-05       Impact factor: 5.182

Review 7.  Neuropeptide and sigma receptors as novel therapeutic targets for the pharmacotherapy of depression.

Authors:  Konstantinos A Paschos; Stavroula Veletza; Ekaterini Chatzaki
Journal:  CNS Drugs       Date:  2009-09       Impact factor: 5.749
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.